6/18/2013 9:15:01 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
LONDON--(BUSINESS WIRE)--Lightlake Therapeutics Inc. (OTCBB: LLTP) (the “Company”, “We” or “Lightlake”), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it will be participating in the 4th Annual OneMedForum New York taking place June 26th and June 27th, 2013 at The Metropolitan Club in New York City. Dr. Roger Crystal, Chief Executive Officer of Lightlake, is scheduled to present an update on the Company’s corporate and clinical developments on Thursday, June 27th at 12:20 p.m. EDT.
Help employers find you! Check out all the jobs and post your resume.
comments powered by